Teva Pharmaceutical Industries Ltd Files Form 8-K for Other Events
TEVA PHARMACEUTICAL INDUSTRIES LTD
Subscribe to track TEVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) - Form 8-K Filing
• Filing Date: September 3, 2026 • Form Type: Form 8-K (Item 8.01: Other Events / Item 9.01: Financial Statements and Exhibits) • Filing Summary: Teva filed an 8-K reporting other corporate events and related inline XBRL financial disclosures. • Accession Number: 0001193125-26-381899
Comprehensive Analysis
Summary of Filing
Company: Teva Pharmaceutical Industries Ltd
CIK: 0000818686
Filing Date: September 3, 2026
Form Type: 8-K
Items Reported: Other Events, Financial Statements and Exhibits
Key Highlights
- Teva Pharmaceutical Industries Ltd submitted a Current Report on Form 8-K providing updates under 'Other Events' accompanied by relevant inline XBRL data and financial footnotes.
- The disclosures incorporate segment details, licensing arrangements, cross-currency swap updates, and debt maturities/redemptions.
- This filing does not report insider transactions or director/executive trading activity.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.